Back to mobile site

Exact Sciences Corp (EXAS) Reports In-Line Q3 EPS Loss of $0.15

November 3, 2011 9:32 AM EDT
Exact Sciences Corp (NASDAQ: EXAS) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $1.03 million versus the consensus estimate of $1.03 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings